Showing results (1911-1920 of 2,199) with videos related to
Sort By:
Pageof 220
Developments in Biological Standardization|June 1, 1977
A three-year evaluation of four commercial equine influenza vaccines in ponies maintained in isolationR Burrows, P R Spooner, D GoodridgeDevelopments in Biological Standardization|June 1, 1977
Host factors and susceptibility to influenza A infection: the effect of ABO blood groups and HL-A antigensJ S Mackenzie, J D Wetherall, P J Fimmel, et al.Developments in Biological Standardization|June 1, 1977
Monitoring of influenza in Israel 1976/77T A Swartz, W Klingberg, C Costin, et al.Developments in Biological Standardization|January 1, 1995
First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigenS Y Gu, T M Huang, L Ruan, et al.Developments in Biological Standardization|January 1, 1995
Efficacy and safety of live recombinant BCG vaccinesM S Hanson, G P Bansal, S Langermann, et al.Developments in Biological Standardization|January 1, 1995
Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effectsS J Cryz, J Kaper, C Tacket, et al.Developments in Biological Standardization|December 13, 1976
Effect of bacterial toxins in serum on the chromosomes of WI-38A M Whitaker, E M SmithDevelopments in Biological Standardization|January 1, 1994
A view on regulatory aspects of live viral vaccine safetyF HoraudDevelopments in Biological Standardization|January 1, 1994
Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVACJ Tartaglia, W I Cox, S Pincus, et al.Pageof 220